ACME United Reports 16% Revenue Growth in Q2 2026, Driven by My Medic Acquisition

ACME United Corporation reported a significant increase in financial performance for the second quarter of 2026, with net sales reaching $62.7 million, a 16% rise from $54.0 million in the same period of 2025. For the first half of 2026, net sales totaled $115.0 million, up 15% from $100.0 million year-over-year. The growth was bolstered by the acquisition of My Medic, which contributed approximately $4.3 million in revenue during the quarter. Excluding this acquisition, sales increased by 8% and 7% for the three and six months ended June 30, 2026, respectively.

The company's gross profit for the second quarter was $26.7 million, representing 42.6% of net sales, compared to $22.1 million (41.0% of net sales) in the prior year. For the first half, gross profit was $47.5 million (41.3% of net sales), up from $40.1 million (40.1% of net sales) in 2025. The increase in gross profit was primarily attributed to the inclusion of My Medic's direct-to-consumer business. However, selling, general, and administrative expenses also rose significantly, totaling $19.9 million for the quarter and $38.9 million for the half-year, reflecting higher personnel costs and increased advertising expenses related to the My Medic acquisition.

Operationally, ACME United's U.S. segment saw a 17% increase in sales for the second quarter, while Canadian sales grew by 1% in U.S. dollars and 3% in local currency. European sales experienced a notable 24% increase in U.S. dollars, driven by higher e-commerce sales and contributions from new product lines. The company’s total assets increased to $200.6 million as of June 30, 2026, up from $171.0 million at the end of 2025, largely due to the acquisition of My Medic and increased inventory levels.

The company’s long-term debt rose to $22.6 million from $11.9 million at the end of 2025, reflecting increased borrowings to support operational growth and acquisitions. In July 2026, ACME United entered into a new $65 million syndicated credit facility to enhance liquidity for future growth and acquisitions. The company reported a current ratio of 3.23 and a long-term debt to equity ratio of 26.3% as of June 30, 2026, indicating a solid financial position.

Looking ahead, ACME United anticipates continued growth driven by strong demand across its product lines and the integration of My Medic. However, the company remains cautious about potential challenges, including inflationary pressures, global trade policies, and supply chain disruptions. Management believes that cash generated from operations, along with available credit, will be sufficient to support the company’s operational needs over the next twelve months.